Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Aktuelles
SiSaf and the University of Leipzig Partner to Develop
Mitarbeiter des Rudolf-Boehm-Institutes
Schlusswort
Neuartige Gentherapie zur Behandlung des Glioblastoms
Achim Aigner | Leipzig University, Germany | | Conferenceseries
Mitarbeiter des Rudolf-Boehm-Institutes
Partnership will develop targeted miRNAs to treat pancreatic cancer - Drug Discovery World (DDW)
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim Prof. Dr. Aigner – Professor – University of Leipzig, Rudolf-Boehm-Institute for Pharmacology and Toxicology | LinkedIn
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Björn Simon
Loop | Achim Aigner
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile
Mitarbeiter des Rudolf-Boehm-Institutes
Aktuelles
Traueranzeigen | trauer.op-online.de
PDF) Targeted CRM197-PEG-PEI/siRNA complexes for therapeutic RNAi in glioblastoma
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Wissenschaftlicher Beirat – Frankfurt Foundation Quality of Medicines
